"O Instituto de Moléstias Cardiovasculares (IMC) foi fundado em dezembro de 1967. Desde o início, seus fundadores enxergavam no local uma vocação de pioneirismo tecnológico, prova disso foi a realização de cirurgia cardíaca com circulação extracorpórea, no final da década de 60, sendo o primeiro a executar esse tipo de procedimento no interior do Estado de São Paulo. Com mais de 50 anos de histórias do coração, o Instituto se tornou uma referência em tratamentos cardíacos na região, com o lema “Assistência, Docência e Ciência”, o IMC possui hoje, aproximadamente, 400 funcionários e 100 médicos renomados. Realiza mais de 3 mil consultas mensais e 421 mil exames ao ano."

During the past decade, Instituto de Molestias Cardiovasculares - IMC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Molestias Cardiovasculares - IMC" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Molestias Cardiovasculares - IMC" are "Atrial Fibrillation" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Instituto de Molestias Cardiovasculares - IMC" in a lesser frequency.

Most popular intervention types in "Instituto de Molestias Cardiovasculares - IMC" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "glimepiride" (1 trials), "glimepiride placebo" (1 trials), "linagliptin" (1 trials) and "linagliptin placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Molestias Cardiovasculares - IMC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Molestias Cardiovasculares - IMC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Instituto de Molestias Cardiovasculares - IMC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Molestias Cardiovasculares - IMC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".